Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils

Immunity
Xiaoming ZhangRichard Lo-Man

Abstract

Neutrophils are one of the first lines of defense against microbial pathogens and are rapidly recruited at the infection site upon inflammatory conditions. We show here that after bacterial stimulation, and in contrast to monocytes and macrophages, murine neutrophils contributed poorly to inflammatory responses; however, they secreted high amounts of the anti-inflammatory cytokine IL-10 in a DAP12 adaptor-Syk kinase and MyD88 adaptor-dependent manner. Cotriggering of TLR-MyD88- and C-type lectin receptor (CLR)-Syk-dependent pathways led to a quick and sustained phosphorylation of p38 MAP and Akt kinases in neutrophils. In vivo, both Gram-negative bacteria and mycobacteria induced the recruitment of neutrophils secreting IL-10. In acute mycobacterial infection, neutrophil-derived IL-10 controlled the inflammatory response of dendritic cells, monocytes and macrophages in the lung. During a chronic infection, neutrophil depletion promoted inflammation and decreased the mycobacterial burden. Therefore, neutrophils can have a previously unsuspected regulatory role during acute and chronic microbial infections.

References

Jul 1, 1984·British Journal of Haematology·A F LopezC J Sanderson
Aug 15, 1998·Annals of the New York Academy of Sciences·G Ricevuti
Aug 18, 1999·Proceedings of the National Academy of Sciences of the United States of America·A B BakkerL L Lanier
Jan 4, 2001·Immunological Reviews·P ScapiniM A Cassatella
Apr 30, 2003·The Journal of Experimental Medicine·Benjamin N GantnerDavid M Underhill
Jun 18, 2003·Trends in Immunology·Vincenzo BrontePaola Zanovello
Jun 28, 2003·Blood·Fumitaka HayashiAndrew D Luster
Nov 20, 2004·Archives of Dermatological Research·Gamze PiskinMarcel B M Teunissen
Apr 20, 2005·The Journal of Experimental Medicine·Klaas P J M van GisbergenYvette van Kooyk
May 17, 2005·Nature Immunology·Jessica A HamermanLewis L Lanier
Aug 3, 2005·The Journal of Experimental Medicine·Isaiah R TurnbullMarco Colonna
Nov 3, 2005·Molecular Immunology·Ruma A PengalSusheela Tridandapani
Jan 21, 2006·Nature Immunology·Taro Kawai, Shizuo Akira
Feb 25, 2006·Cell·Shizuo AkiraOsamu Takeuchi
Nov 18, 2006·Nature Immunology·Jörg H FritzStephen E Girardin
Sep 9, 2008·Nature Immunology·Sho YamasakiTakashi Saito
Jan 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sho YamasakiTakashi Saito

❮ Previous
Next ❯

Citations

May 16, 2012·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Hildur H ArnardottirIngibjorg Hardardottir
Apr 24, 2010·Cancer Metastasis Reviews·Graziella SolinasPaola Allavena
Sep 29, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Antonio SicaElena Riboldi
Jul 31, 2013·Immunobiology·Maria Rosaria GaldieroSébastien Jaillon
Apr 2, 2013·Trends in Immunology·Christina J Thomas, Kate Schroder
Apr 1, 2011·Enfermedades infecciosas y microbiología clínica·Pere-Joan Cardona, Juraj Ivanyi
Mar 30, 2011·Immunology and Cell Biology·Yi ChenMark P Hedger
May 2, 2012·Immunology and Cell Biology·Jiang-Hu PiaoHiroyasu Nakano
Oct 21, 2011·Nature Immunology·Martin S DaveyMarco A Cassatella
Feb 16, 2010·Nature Reviews. Immunology·Margarida Saraiva, Anne O'Garra
Feb 26, 2011·Nature Reviews. Immunology·George Hajishengallis, John D Lambris
Jul 26, 2011·Nature Reviews. Immunology·Alberto MantovaniSébastien Jaillon
Feb 26, 2013·Nature Reviews. Immunology·Elzbieta Kolaczkowska, Paul Kubes
Mar 31, 2010·The Journal of Experimental Medicine·Anca DorhoiStefan H E Kaufmann
Mar 7, 2012·The Journal of Experimental Medicine·Baptiste N JaegerSophie Ugolini
Jan 23, 2013·The Journal of Experimental Medicine·Chiao-Wen Yang, Emil R Unanue
Jul 5, 2013·The Journal of Experimental Medicine·Attila Mócsai
Aug 9, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Neng F KurniatiPeter Heeringa
Nov 12, 2010·Cold Spring Harbor Perspectives in Biology·Clifford A Lowell
Jul 21, 2010·Infection and Immunity·Natalia MuñozJosé A Chabalgoity
Mar 26, 2011·The Journal of Clinical Investigation·Clifford A Lowell
Dec 14, 2011·The Journal of Clinical Investigation·Janesh PillayLeo Koenderman
Jul 19, 2013·The Journal of Clinical Investigation·Joanna M WarszawskaSylvia Knapp
Nov 26, 2010·Journal of Leukocyte Biology·Lee M OcuinRonald P DeMatteo
Aug 13, 2013·PLoS Neglected Tropical Diseases·João Filipe MeninoFernando Rodrigues
Mar 21, 2012·Critical Reviews in Immunology·Shankar Subramanian Iyer, Gehong Cheng
Jan 26, 2013·Stem Cells Translational Medicine·Andrea Loewendorf, Marie Csete
Apr 18, 2014·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Linda D HazlettSharon A McClellan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.